{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:58:38Z","timestamp":1766023118765,"version":"3.48.0"},"reference-count":33,"publisher":"e-Century Publishing Corporation","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Am J Cancer Res"],"DOI":"10.62347\/cvay8707","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:08:31Z","timestamp":1719533311000},"page":"2868-2880","source":"Crossref","is-referenced-by-count":0,"title":["Cdc14B\/Cyclin B1 signaling modulates the pathogenesis of sonic hedgehog subtype medulloblastoma"],"prefix":"10.62347","volume":"14","author":[{"given":"Ting","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"48694","published-online":{"date-parts":[[2024]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1126\/science.1198056","article-title":"The genetic land&#xFFFD;scape of the childhood cancer medulloblastoma","volume":"331","author":"Parsons","year":"2011","unstructured":"Parsons DW, Li M, Zhang X, Jones S, Leary RJ, Lin JC, Boca SM, Carter H, Samayoa J, Bettegowda C, Gallia GL, Jallo GI, Binder ZA, Nikolsky Y, Hartigan J, Smith DR, Gerhard DS, Fults DW, VandenBerg S, Berger MS, Marie SK, Shinjo SM, Clara C, Phillips PC, Minturn JE, Biegel JA, Judkins AR, Resnick AC, Storm PB, Curran T, He Y, Rasheed BA, Friedman HS, Keir ST, McLendon R, Northcott PA, Taylor MD, Burger PC, Riggins GJ, Karchin R, Parmigiani G, Bigner DD, Yan H, Papadopoulos N, Vogelstein B, Kinzler KW and Velculescu VE. The genetic land&#xFFFD;scape of the childhood cancer medulloblastoma. Science 2011; 331: 435-439.","journal-title":"Science"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"176","DOI":"10.3389\/fonc.2014.00176","article-title":"Pediatric medulloblastoma - update on molecular classification driving targeted therapies","volume":"4","author":"DeSouza","year":"2014","unstructured":"DeSouza RM, Jones BR, Lowis SP and Kurian KM. Pediatric medulloblastoma - update on molecular classification driving targeted therapies. Front Oncol 2014; 4: 176.","journal-title":"Front Oncol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.3390\/cancers14092285","article-title":"New developments in the pathogenesis, therapeutic targeting, and treatment of pediatric medulloblastoma","volume":"14","author":"Fang","year":"2022","unstructured":"Fang FY, Rosenblum JS, Ho WS and Heiss JD. New developments in the pathogenesis, therapeutic targeting, and treatment of pediatric medulloblastoma. Cancers (Basel) 2022; 14: 2285.","journal-title":"Cancers (Basel)"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1093\/annonc\/mdz164","article-title":"Molecular pathology of tumors of the central nervous system","volume":"30","author":"Kristensen","year":"2019","unstructured":"Kristensen BW, Priesterbach-Ackley LP, Petersen JK and Wesseling P. Molecular pathology of tumors of the central nervous system. Ann Oncol 2019; 30: 1265-1278.","journal-title":"Ann Oncol"},{"key":"ref4","unstructured":"Li KK, Lau KM and Ng HK. Signaling pathway and molecular subgroups of medulloblastoma. Int J Clin Exp Pathol 2013; 6: 1211-1222."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nrneurol.2012.78","article-title":"The clinical implications of medulloblastoma subgroups","volume":"8","author":"Northcott","year":"2012","unstructured":"Northcott PA, Korshunov A, Pfister SM and Taylor MD. The clinical implications of medulloblastoma subgroups. Nat Rev Neurol 2012; 8: 340-351.","journal-title":"Nat Rev Neurol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1038\/nrm3598","article-title":"The mechanisms of Hedgehog signalling and its roles in development and disease","volume":"14","author":"Briscoe","year":"2013","unstructured":"Briscoe J and Therond PP. The mechanisms of Hedgehog signalling and its roles in development and disease. Nat Rev Mol Cell Biol 2013; 14: 416-429.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1200\/JCO.2017.72.7842","article-title":"Medulloblastoma: from myth to molecular","volume":"35","author":"Ramaswamy","year":"2017","unstructured":"Ramaswamy V and Taylor MD. Medulloblastoma: from myth to molecular. J Clin Oncol 2017; 35: 2355-2363.","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/cr.1998.2","article-title":"The role of the hedgehog\/patched signaling pathway in epithelial stem cell proliferation: from fly to human","volume":"8","author":"Parisi","year":"1998","unstructured":"Parisi MJ and Lin H. The role of the hedgehog\/patched signaling pathway in epithelial stem cell proliferation: from fly to human. Cell Res 1998; 8: 15-21.","journal-title":"Cell Res"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Robbins DJ, Fei DL and Riobo NA. The Hedgehog signal transduction network. Sci Signal 2012; 5: re6.","DOI":"10.1126\/scisignal.2002906"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1093\/emboj\/20.9.2214","article-title":"Patched1 interacts with cyclin B1 to regulate cell cycle progression","volume":"20","author":"Barnes","year":"2001","unstructured":"Barnes EA, Kong M, Ollendorff V and Donoghue DJ. Patched1 interacts with cyclin B1 to regulate cell cycle progression. EMBO J 2001; 20: 2214-2223.","journal-title":"EMBO J"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/S0955-0674(00)00149-6","article-title":"Control of mitosis by changes in the subcellular location of cyclin-B1-Cdk1 and Cdc25C","volume":"12","author":"Takizawa","year":"2000","unstructured":"Takizawa CG and Morgan DO. Control of mitosis by changes in the subcellular location of cyclin-B1-Cdk1 and Cdc25C. Curr Opin Cell Biol 2000; 12: 658-665.","journal-title":"Curr Opin Cell Biol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov 2022; 12: 31-46.","journal-title":"Cancer Discov"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ncb2633","article-title":"Centrosomal MPF triggers the mitotic and morphogenetic switches of fission yeast","volume":"15","author":"Grallert","year":"2013","unstructured":"Grallert A, Patel A, Tallada VA, Chan KY, Bagley S, Krapp A, Simanis V and Hagan IM. Centrosomal MPF triggers the mitotic and morphogenetic switches of fission yeast. Nat Cell Biol 2013; 15: 88-95.","journal-title":"Nat Cell Biol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/336430a0","article-title":"Universal and essential role of MPF\/cdc2+","volume":"336","author":"Niwa","year":"1988","unstructured":"Niwa O and Yanagida M. Universal and essential role of MPF\/cdc2+. Nature 1988; 336: 430.","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41580-021-00404-3","article-title":"Cell cycle control in cancer","volume":"23","author":"HK","year":"2022","unstructured":"Matthews HK, Bertoli C and de Bruin RAM. Cell cycle control in cancer. Nat Rev Mol Cell Biol 2022; 23: 74-88.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Tumurbaatar I, Cizmecioglu O, Hoffmann I, Grummt I and Voit R. Human Cdc14B promotes progression through mitosis by dephosphorylating Cdc25 and regulating Cdk1\/cyclin B activity. PLoS One 2011; 6: e14711.","DOI":"10.1371\/journal.pone.0014711"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Bai GY, Choe MH, Kim JS and Oh JS. Mis12 controls cyclin B1 stabilization via Cdc14B-mediated APC\/C(Cdh1) regulation during meiotic G2\/M transition in mouse oocytes. Development 2020; 147: dev185322.","DOI":"10.1242\/dev.185322"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"102363","DOI":"10.1016\/j.jbc.2022.102363","article-title":"Phosphatidic acid inhibits inositol synthesis by inducing nuclear translocation of kinase IP6K1 and repression of myo-inositol-3-P synthase","volume":"298","author":"Lazcano","year":"2022","unstructured":"Lazcano P, Schmidtke MW, Onu CJ and Greenberg ML. Phosphatidic acid inhibits inositol synthesis by inducing nuclear translocation of kinase IP6K1 and repression of myo-inositol-3-P synthase. J Biol Chem 2022; 298: 102363.","journal-title":"J Biol Chem"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1111\/j.1349-7006.2011.02010.x","article-title":"Hedgehog signaling pathway as a therapeutic target in various types of cancer","volume":"102","author":"Onishi","year":"2011","unstructured":"Onishi H and Katano M. Hedgehog signaling pathway as a therapeutic target in various types of cancer. Cancer Sci 2011; 102: 1756-1760.","journal-title":"Cancer Sci"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s40265-013-0045-z","article-title":"Hedgehog signaling pathway and cancer therapeutics: progress to date","volume":"73","author":"Ruch","year":"2013","unstructured":"Ruch JM and Kim EJ. Hedgehog signaling pathway and cancer therapeutics: progress to date. Drugs 2013; 73: 613-623.","journal-title":"Drugs"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41572-019-0063-6","article-title":"Medulloblastoma","volume":"5","author":"Northcott","year":"2019","unstructured":"Northcott PA, Robinson GW, Kratz CP, Mabbott DJ, Pomeroy SL, Clifford SC, Rutkowski S, Ellison DW, Malkin D, Taylor MD, Gajjar A and Pfister SM. Medulloblastoma. Nat Rev Dis Primers 2019; 5: 11.","journal-title":"Nat Rev Dis Primers"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1158\/0008-5472.CAN-17-1631","article-title":"Nkx2-2as suppression contributes to the pathogenesis of sonic hedgehog medulloblastoma","volume":"78","author":"Zhang","year":"2018","unstructured":"Zhang Y, Wang T, Wang S, Xiong Y, Zhang R, Zhang X, Zhao J, Yang AG, Wang L and Jia L. Nkx2-2as suppression contributes to the pathogenesis of sonic hedgehog medulloblastoma. Cancer Res 2018; 78: 962-973.","journal-title":"Cancer Res"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"864035","DOI":"10.3389\/fcell.2022.864035","article-title":"Sonic hedgehog signaling in cerebellar development and cancer","volume":"10","author":"Wang","year":"2022","unstructured":"Wang W, Shiraishi R and Kawauchi D. Sonic hedgehog signaling in cerebellar development and cancer. Front Cell Dev Biol 2022; 10: 864035.","journal-title":"Front Cell Dev Biol"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Mohamed TMA, Ang YS, Radzinsky E, Zhou P, Huang Y, Elfenbein A, Foley A, Magnitsky S and Srivastava D. Regulation of cell cycle to stimulate adult cardiomyocyte proliferation and cardiac regeneration. Cell 2018; 173: 104-116, e12.","DOI":"10.1016\/j.cell.2018.02.014"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1111\/cns.13835","article-title":"Targeting AKT and CK2 represents a novel therapeutic strategy for SMO constitutive activation-driven medulloblastoma","volume":"28","author":"Yao","year":"2022","unstructured":"Yao YL, Wang YX, Yang FC, Wang C, Mao M, Gai QJ, He J, Qin Y, Yao XX, Lan X, Zhu J, Lu HM, Zeng H, Yao XH, Bian XW and Wang Y. Targeting AKT and CK2 represents a novel therapeutic strategy for SMO constitutive activation-driven medulloblastoma. CNS Neurosci Ther 2022; 28: 1033-1044.","journal-title":"CNS Neurosci Ther"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Moriya H, Shimizu-Yoshida Y and Kitano H. In vivo robustness analysis of cell division cycle genes in Saccharomyces cerevisiae. PLoS Genet 2006; 2: e111.","DOI":"10.1371\/journal.pgen.0020111"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/s12935-020-01304-w","article-title":"The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review","volume":"20","author":"Liu","year":"2020","unstructured":"Liu K, Zheng M, Lu R, Du J, Zhao Q, Li Z, Li Y and Zhang S. The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review. Cancer Cell Int 2020; 20: 213.","journal-title":"Cancer Cell Int"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.molcel.2011.01.012","article-title":"Ultrasensitivity in the regulation of Cdc25C by Cdk1","volume":"41","author":"Trunnell","year":"2011","unstructured":"Trunnell NB, Poon AC, Kim SY and Ferrell JE Jr. Ultrasensitivity in the regulation of Cdc25C by Cdk1. Mol Cell 2011; 41: 263-274.","journal-title":"Mol Cell"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Tan T, Wu C, Liu B, Pan BF, Hawke DH, Su Z, Liu S, Zhang W, Wang R, Lin SH and Kuang J. Revisiting the multisite phosphorylation that produces the M-phase supershift of key mitotic regulators. Mol Biol Cell 2022; 33: ar115.","DOI":"10.1091\/mbc.E22-04-0118"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1038\/s41467-020-15059-5","article-title":"Antagonistic activities of CDC14B and CDK1 on USP9X regulate WT1-dependent mitotic transcription and survival","volume":"11","author":"Dietachmayr","year":"2020","unstructured":"Dietachmayr M, Rathakrishnan A, Karpiuk O, von Zweydorf F, Engleitner T, Fernandez-Saiz V, Schenk P, Ueffing M, Rad R, Eilers M, Gloeckner CJ, Clemm von Hohenberg K and Bassermann F. Antagonistic activities of CDC14B and CDK1 on USP9X regulate WT1-dependent mitotic transcription and survival. Nat Commun 2020; 11: 1268.","journal-title":"Nat Commun"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1309\/AJCP4PE4JPSRGBQS","article-title":"Loss of CDC14B expression in clear cell renal cell carcinoma: meta-analysis of microarray data sets","volume":"141","author":"Kim","year":"2014","unstructured":"Kim Y, Choi JW, Lee JH and Kim YS. Loss of CDC14B expression in clear cell renal cell carcinoma: meta-analysis of microarray data sets. Am J Clin Pathol 2014; 141: 551-558.","journal-title":"Am J Clin Pathol"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1101\/gad.349596.122","article-title":"Primary cilia control translation and the cell cycle in medulloblastoma","volume":"36","author":"Youn","year":"2022","unstructured":"Youn YH, Hou S, Wu CC, Kawauchi D, Orr BA, Robinson GW, Finkelstein D, Taketo MM, Gilbertson RJ, Roussel MF and Han YG. Primary cilia control translation and the cell cycle in medulloblastoma. Genes Dev 2022; 36: 737-751.","journal-title":"Genes Dev"}],"container-title":["American Journal of Cancer Research"],"original-title":[],"link":[{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/6\/ajcr0152179.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T01:53:57Z","timestamp":1766022837000},"score":1,"resource":{"primary":{"URL":"https:\/\/e-century.us\/files\/ajcr\/14\/6\/ajcr0152179.pdf"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.62347\/cvay8707","relation":{},"ISSN":["2156-6976"],"issn-type":[{"type":"electronic","value":"2156-6976"}],"subject":[],"published":{"date-parts":[[2024]]}}}